FDA Approves Ebanga

FDA Approves Ebanga

FDA Approves Ebanga (ansuvimab-zykl) for the Treatment of Zaire Ebolavirus Infection December 21, 2020 — The U.S. Food and Drug Administration approved Ebanga (Ansuvimab-zykl), a human monoclonal antibody, for the treatment for Zaire ebolavirus (Ebolavirus) infection in adults and children….

Read More
Are you allergic to your Christmas tree?

Are you allergic to your Christmas tree?

Fox News Flash top headlines for December 21 Fox News Flash top headlines are here. Check out what’s clicking on Foxnews.com. The holidays may look a little different this year due to the ongoing coronavirus pandemic, but that doesn’t mean decorating…

Read More
Rimegepant bests placebo for preventing migraine

Rimegepant bests placebo for preventing migraine

(HealthDay)—Taken every other day, rimegepant demonstrates efficacy for the preventive treatment of migraine, according to a study published online Dec. 15 in The Lancet. Robert Croop, M.D., from Biohaven Pharmaceuticals in New Haven, Connecticut, and colleagues compared the efficacy of…

Read More